Onyx Biotec Limited (NSE:ONYX)
India · Delayed Price · Currency is INR 37.50
-1.75 (-4.46%)
At close: Sep 4, 2026
Onyx Biotec Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -2.14 | 49.54 | 36.35 | 18.45 | 33.53 |
Depreciation & Amortization | 30.52 | 30.47 | 18.67 | 14.91 | 14.48 |
Loss (Gain) From Sale of Assets | - | -9.54 | - | - | - |
Other Operating Activities | 6 | 40.34 | 30.44 | 13.04 | 11.38 |
Change in Accounts Receivable | -72.66 | -48.6 | -102.97 | 33.42 | -60 |
Change in Inventory | 20.6 | -69.97 | -27.74 | -32.76 | 2.99 |
Change in Accounts Payable | 9.15 | 29.46 | 68.63 | 26.06 | 30.08 |
Change in Other Net Operating Assets | -6.41 | -7.54 | -8.21 | -10.75 | -27.6 |
Operating Cash Flow | -14.94 | 14.17 | 15.16 | 62.36 | 4.85 |
Operating Cash Flow Growth | - | -6.54% | -75.69% | 1184.71% | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -49.87 | -10.55 | -32.23 | -227.37 | -57.86 |
Sale of Property, Plant & Equipment | - | 15.39 | - | - | - |
Other Investing Activities | 4.04 | 1.73 | 0.75 | 0.65 | 0.1 |
Investing Cash Flow | -45.83 | 6.56 | -31.48 | -226.72 | -57.76 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 47.81 | - | - | 75.99 | 24.79 |
Long-Term Debt Issued | - | - | 55.75 | 93.86 | 32.34 |
Total Debt Issued | 47.81 | - | 55.75 | 169.84 | 57.13 |
Short-Term Debt Repaid | - | -14.88 | -40.23 | - | - |
Long-Term Debt Repaid | -20.67 | -168.34 | - | - | - |
Total Debt Repaid | -20.67 | -183.23 | -40.23 | - | - |
Net Debt Issued (Repaid) | 27.14 | -183.23 | 15.52 | 169.84 | 57.13 |
Issuance of Common Stock | - | 253.8 | 36.46 | - | - |
Other Financing Activities | -12.12 | -19.86 | -21.07 | -5.55 | -5.15 |
Financing Cash Flow | 15.02 | 50.72 | 30.91 | 164.3 | 51.98 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | - | -42.83 | 0 |
Net Cash Flow | -45.75 | 71.45 | 14.59 | -42.9 | -0.93 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -64.81 | 3.62 | -17.07 | -165.01 | -53 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -9.33% | 0.58% | -3.17% | -41.78% | -11.82% |
Free Cash Flow Per Share | -3.63 | 0.24 | -1.43 | -13.98 | -4.49 |
Levered Free Cash Flow | -71.23 | -24.9 | -57.82 | -172.52 | - |
Unlevered Free Cash Flow | -63.66 | -12.44 | -44.66 | -168.99 | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 12.11 | 19.86 | 21.07 | 5.55 | 5.15 |
Change in Working Capital | -49.32 | -96.64 | -70.29 | 15.97 | -54.53 |